The complex mechanisms by which the IL-33/ST2 signaling pathway expresses a dual function in AKI may be due to the binding of IL-33 to ST2 on the surface of different immune cells and the specific immune microenvironment in which it resides. Here, IL33 is linked to acute kidney injury.